Lim, W.-J.; Lee, M.; Oh, Y.; Fang, X.-Q.; Lee, S.; Lim, C.-H.; Park, J.; Lim, J.-H.
Statins Decrease Programmed Death-Ligand 1 (PD-L1) by Inhibiting AKT and β-Catenin Signaling. Cells 2021, 10, 2488.
https://doi.org/10.3390/cells10092488
AMA Style
Lim W-J, Lee M, Oh Y, Fang X-Q, Lee S, Lim C-H, Park J, Lim J-H.
Statins Decrease Programmed Death-Ligand 1 (PD-L1) by Inhibiting AKT and β-Catenin Signaling. Cells. 2021; 10(9):2488.
https://doi.org/10.3390/cells10092488
Chicago/Turabian Style
Lim, Woo-Jin, Mingyu Lee, Yerin Oh, Xue-Quan Fang, Sujin Lee, Chang-Hoon Lim, Jooho Park, and Ji-Hong Lim.
2021. "Statins Decrease Programmed Death-Ligand 1 (PD-L1) by Inhibiting AKT and β-Catenin Signaling" Cells 10, no. 9: 2488.
https://doi.org/10.3390/cells10092488
APA Style
Lim, W.-J., Lee, M., Oh, Y., Fang, X.-Q., Lee, S., Lim, C.-H., Park, J., & Lim, J.-H.
(2021). Statins Decrease Programmed Death-Ligand 1 (PD-L1) by Inhibiting AKT and β-Catenin Signaling. Cells, 10(9), 2488.
https://doi.org/10.3390/cells10092488